Relevant OCF funded peer reviewed science

2017

Significant Changes in Sexual Behavior After a Diagnosis of Human Papillomavirus-Positive and Human Papillomavirus – Negative Oral CancerMiren Taberna, MD, Ronald C. Inglehart, Robert K. L. Pickard, Carole Fakhry, MD, MPH, Amit Agrawal, MD, Mira L. Katz, PhD and Maura L. Gillison, MD, PhD, Cancer Jan 2017

2016

• Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

R.L. Ferris, G. Blumenschein, Jr., J. Fayette, J. Guigay, A.D. Colevas, L. Licitra, K. Harrington, S. Kasper, E.E. Vokes, C. Even, F. Worden, N.F. Saba, L.C. Iglesias Docampo, R. Haddad, T. Rordorf, N. Kiyota, M. Tahara, M. Monga, M. Lynch, W.J. Geese, J. Kopit, J.W. Shaw, and M.L. Gillison – The New England Journal of Medicine, October 9, 2016

• Rising Population of Survivors of Oral Squamous Cell Cancer in the United States

Mira A. Patel BA, Amanda L. Blackford, ScM, Eleni M. Rettig MD, Jeremy D. Richmon MD, David W. Eisele MD and Carole Fakhry MD, MPH – Cancer, May 1, 2016

2015

• Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer

Carole Fakhry, Jesse R. Qualliotine, Zhe Zhang, Nishant Agrawal, Daria A. Gaykalova, Justin A. Bishop, Rathan M. Subramaniam,Wayne M. Koch, Christine H. Chung, David W. Eisele, Joseph Califano, and Raphael P. Viscidi – AACR, December 23, 2015

• Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma

Maura L.Gillison, Anil K. Chaturvedi, William F. Anderson, and Carole Fakhry – Cancer, September 8, 2015

• Oropharyngeal cancer survivorship in Denmark, 1977–2012

Carole Fakhry, Klaus K. Andersen, David W. Eisele, Maura L. Gillison, Oral Oncology, August 2015

• Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus–Related Oropharyngeal Carcinoma

Eleni M. Rettig, MD; AliciaWentz, MA; Marshall R. Posner, MD; Neil D. Gross, MD; Robert I. Haddad, MD;Maura L. Gillison, MD, PhD; Carole Fakhry, MD; Harry Quon, MD; Andrew G. Sikora, MD, PhD;William J. Stott, CCRP; Jochen H. Lorch, MD; Christine G. Gourin, MD; Yingshi Guo, MS;Weihong Xiao, MD;Brett A. Miles, DDS, MD; Jeremy D. Richmon, MD; Peter E. Andersen, MD; Krzysztof J. Misiukiewicz, MD;Christine H. Chung, MD; Jennifer E. Gerber, MSc; Shirani D. Rajan, MSPH; Gypsyamber D’Souza, PhD – American Medical Association, July 30, 2015

• Surgical Salvage Improves Overall Survival for Patients With HPV-Positive and HPV-Negative Recurrent Locoregional and Distant Metastatic Oropharyngeal Cancer

Theresa Guo, MD; Jesse R. Qualliotine, MD; Patrick K. Ha, MD, Joseph A. Califano MD, Young Kim, MD, PhD, John R. Saunders MD, Ray G. Blanco MD, Gypsyamber D’Souza MD, Zhe Zhang MD, Christine H. Chung MD, Ana Kiess MD, PhD, Christine G. Gourin MD, Wayne Koch MD, Jeremy D. Richmon MD, Nishant Agrawal, MD, David W. Eisele MD and Carole Fakhry MD, MPH – American Society of Clinical Oncology, June 15, 2015

• The Impact of Tonsillectomy upon the Risk of Oropharyngeal Carcinoma Diagnosis and Prognosis in the Danish Cancer Registry

Carole Fakhry, Klaus K. Andersen3, Jane Christensen, Nishant Agrawal, and David W. Eisele – American Society of Clinical Oncology, April 20, 2015

• Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk

Eleni M. Rettig, Christine H. Chung, Justin A. Bishop, Jason D. Howard, Rajni Sharma, Ryan J. Li, Christopher Douville, Rachel Karchin, Evgeny Izumchenko1, David Sidransky,Wayne Koch, Joseph Califano, Nishant Agrawal and Carole Fakhry – American Association for Cancer Research, January 29, 2015

• Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus–Related Oropharyngeal Carcinoma

Eleni M. Rettig, MD; AliciaWentz, MA; Marshall R. Posner, MD; Neil D. Gross, MD; Robert I. Haddad, MD; Maura L. Gillison, MD, PhD; Carole Fakhry, MD; Harry Quon, MD; Andrew G. Sikora, MD, PhD;
William J. Stott, CCRP; Jochen H. Lorch, MD; Christine G. Gourin, MD; Yingshi Guo, MS;Weihong Xiao, MD; Brett A. Miles, DDS, MD; Jeremy D. Richmon, MD; Peter E. Andersen, MD; Krzysztof J. Misiukiewicz, MD;
Christine H. Chung, MD; Jennifer E. Gerber, MSc; Shirani D. Rajan, MSPH; Gypsyamber D’Souza, PhD, Journal of the American Medical Association, Jan 2015

2014 – 2008

• Low Etiologic Fraction for High-Risk Human Papillomavirus in Oral Cavity Squamous Cell Carcinomas

Dr. Gillison, Mark W. Lingen, Oral Oncology, 2012

• Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

Dr. Gillison, Kian Ang, The New England Journal of Medicine, June 2010

• Salivary Proteomics for Oral Cancer BiomarkerDiscovery

Shen Hu, Martha Arellano, Pinmanee Boontheung, JianghuaWang, Hui Zhou, JiangJiang, David Elashoff, RogerWei, Joseph A. Loo and David T.Wong – American Association for Cancer Research, October 1, 2008